LDS/Medical Tests/Trypanosoma cruzi (T. cruzi) Antibody, IgG

Trypanosoma cruzi (T. cruzi) Antibody, IgG

Trypanosoma cruzi (T. cruzi) is a protozoan parasite that is the primary causative agent in Chagas disease. Chagas disease is an acute or chronic infection caused by this blood flagellate.  This parasite is most commonly found in Central and South America among humans, domestic and wild animals, and among individuals living in the mud of thatch houses. The carrier, or vector, for this disease is the triatomine bug, which becomes infected by feeding from the blood of an infected human or animal.  The bug hides during the day, but emerges at night to feed, usually on the face of the victim (hence the name kissing bug or reduviid bug). The typical mode of infection is by the reduviid bug sucking the blood of its victim.  After it feeds, it defecates on or near the feeding site and its feces contains the parasites' trypomastigotes.  The host then scratches at the site or mucous membrane and innoculates the parastite at the site.  Once inside the host, the parasite invades cells and differentiates into amastigotes.  The amastigotes divide and become trypomastigotes and invade the blood stream, where they can be taken in by another triatomine bug. There are other modes of transmission such as mother to child (perinatal/vertical transfer), blood transfusions, organ transplantion and possibly by food ingestion.

The T. cruzi parasite reproduces once it enters the bloodstream and can then travel to other tissues of the body or be taken up by other vectors and transmitted to additional hosts. Average time of active infection is 90 days, but even if the patient has no symptoms, he or she will remain infected throughout their lives. The organism can be demonstrated in stained peripheral blood smears during the acute infection, which usually resolves spontaneously.  chronic infections too are often assymptomatic, but may result in life-threatening complications such as cardiomegaly and megacolon.  The diseased tissues contain the parasite as the amastigote during the chronic phase, but organisms are not seen in the peripheral blood in the chronic phase.  During this phase, diagnosis is made by blood antibody testing or by tissue biopsy.  Antibody becomes detectable within 3 - 4 weeks of infection.  During the chronic phase, antibody levels may fluctuate and eventually become undetectable.  The Centers for Disease Control estimates 16-18 million cases of Chagas disease annually, and of those cases, approximately 50,000 individuals will die of the disease. Physicians should consult an infectious disease specialist due to the typical ineffectiveness of treatment for Trypanosoma cruzi.  Patients who are assymptomatic and antibody positive may transmit the disease through tissue or blood.

Antitrypanosomal therapy is always recommended for acute and early-stage infection, although none of these therapies are currently approved by the FDA in the United States. Antitrypanosomal drugs such as benznidazole and nifurtimox in the United States must be acquired through the CDC. Most stages of T. cruzi infection have no symptoms, but when symptoms are present, typically include Romaña’s sign (edema of the eyelid or ocular tissue-one swollen eye), fatigue, fever, rash, loss of appetite, diarrhea, and vomiting. This test is also used for blood and tissue donor screening.

  • Aids in diagnosis of Chagas Disease or American Trypanosomiasis
  • Congestive cardiomyopathy
  • Ventricular arrhythmias
  • Conduction system abnormalities
  • Aid in treatment regimen for Chagas Disease or American Trypanosomiasis

Positive in:

  • Chagas Disease
  • American Trypanosomiasis

Positive test result: Indicative of active infection with T. cruzi, confirmatory testing suggested.

Negative test result: Patient not infected with T. cruzi.

Negative (Non-reactive)


 

 

 

ELISA testing, Immunoassay, Blood smear (During the acute phase of infection, parasites may be detected on fresh preparations of stained peripheral blood smears).

Whole blood collected in EDTA lavender or purple top tube, Serum collected in serum separated tube (SST).

  • Ambient: 48 hours
  • Refrigerated: 1 week
  • Frozen: 3 months
West Nile virus analysis, HIV, blood donor screening, organ donor screening.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Curr Pharm Des. 2002;8(4):287-95. [PMID: 11860367]
  • Curr Med Chem. 2010;17(5):423-52. [PMID: 20015038]
  • Chagas Disease After Organ Transplantation – Los Angeles, California, 2006 MMWR. July 28, 2006 / 55(29);798-800
  • Rev Soc Bras Med Trop. 2012 Jun; 45(3): 286-96.  [PMID: 22760123]